Serum Osteopontin and Procollagen Type 1 N-Terminal Propeptide Concentrations: Links to Liver Function, Muscle Mass, and Bone Mineral Density in MASLD and Hypertension
Background/Objectives: Increasing evidence suggests that metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertension (HTN), a well-established cardiometabolic risk factor, both negatively impact bone metabolism. This study aimed to investigate the associations between bone turn...
Saved in:
| Main Authors: | Anna F. Sheptulina, Anastasia Yu. Elkina, Elvira M. Mamutova, Yuriy S. Timofeev, Victoria A. Metelskaya, Oxana M. Drapkina |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/15/7/459 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticonvulsants impacting bone metabolism: interim results from a cross-sectional study
by: N. A. Sivakova, et al.
Published: (2024-10-01) -
Development and validation of a novel prediction model for osteoporosis: from serotonin to fat-soluble vitamins
by: Jinpeng Wang, et al.
Published: (2025-02-01) -
Hypertension and reduced bone mineral density: unexpected pathogenetic mechanisms
by: A. F. Sheptulina, et al.
Published: (2024-06-01) -
Clinical outcomes and bone marker changes in postmenopausal women with dental implants: a one-year prospective study
by: Jung Min Cho, et al.
Published: (2025-05-01) -
Serum Irisin, Myostatin, and Myonectin Correlate with Metabolic Health Markers, Liver Disease Progression, and Blood Pressure in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Hypertension
by: Anna F. Sheptulina, et al.
Published: (2024-10-01)